Search clinical trials for: Signifor (pasireotide)
Total 86 results
-
Columbia UniversityTerminatedPituitary Tumor | ACTH-producing Pituitary TumourUnited States
-
Zealand University HospitalUnknownHypoglycemia, ReactiveDenmark
-
Montefiore Medical CenterNo longer availableCongenital HyperinsulinismUnited States
-
Erasmus Medical CenterNovartisUnknown
-
Hospices Civils de LyonCompleted
-
University of Colorado, DenverNovartisCompletedHyperinsulinemic Hypoglycemia | Post Gastrointestinal Tract Surgery HypoglycaemiaUnited States
-
Emory UniversityNovartisCompletedNeuroendocrine TumorsUnited States
-
Universidade Federal do Rio de JaneiroCompletedNon-functioning Pituitary Adenomas | ProlactinomasBrazil
-
RECORDATI GROUPActive, not recruitingProstate Cancer | Neuroendocrine Tumors | Acromegaly | Cushing's Disease | Dumping Syndrome | Pituitary Tumors | Ectopic ACTH Secreting (EAS) Tumors | Melanoma Negative for bRAF | Melanoma Negative for nRASBelgium, Brazil, Bulgaria, Canada, France, Germany, Italy, Japan, Korea, Republic of, Thailand, Turkey, United States, Argentina, Greece, Hungary, India, Israel, Malaysia, Mexico, Netherlands, Peru, Poland, Portugal, Romania, Russian Federation and more
-
Novartis PharmaceuticalsCompleted
-
Zealand University HospitalCompletedObesity | Hypoglycemia | Surgery
-
Novartis PharmaceuticalsCompletedGastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic SystemGermany
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
RECORDATI GROUPRecruitingPost-Bariatric HypoglycemiaUnited States, Belgium, France, Italy, Spain, United Kingdom
-
Robert R. Henry, MDVeterans Medical Research FoundationCompletedHyperglycemiaUnited States
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States
-
Patrick Y. Wen, MDMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; Northwestern... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompleted
-
Alliance Pour La Recherche en CancerologieCompleted
-
NYU Langone HealthUnited States Department of DefenseCompletedAtypical Ductal Breast Hyperplasia | Lobular Carcinoma in Situ (LCIS) | Atypical Lobular Hyperplasia (ALH) of BreastUnited States
-
Novartis PharmaceuticalsCompletedDose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)Neuroendocrine TumorsUnited States
-
NYU Langone HealthTerminatedDuctal Carcinoma in SituUnited States
-
University of PennsylvaniaTerminatedGonadotroph AdenomasUnited States
-
Novartis PharmaceuticalsTerminatedPituitary Neoplasm | Pancreatic Neoplasm | Ectopic ACTH Syndrome | Nelson SyndromeGermany, Italy, Australia, Russian Federation, Spain, Thailand, France, Canada, Brazil, United States, Argentina, Mexico
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedEverolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaUnited States
-
Mayo ClinicCompletedAutosomal Dominant Polycystic Kidney Disease | Polycystic Liver Disease | Autosomal Dominant Polycystic Liver Disease | Somatostatin AnalogsUnited States
-
Novartis PharmaceuticalsCompletedAcromegalyItaly, Belgium, United Kingdom, Bulgaria, Turkey, France, Portugal, China, Argentina, Brazil, Colombia, Hungary, Malaysia, Mexico, Romania
-
Lynn FeunCompletedHepatocellular CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Pituitary GigantismJapan
-
Novartis PharmaceuticalsCompletedNeuroendocrine Carcinoma of the Lung and ThymusItaly, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
-
University of PalermoCompleted
-
Novartis PharmaceuticalsCompletedDumping SyndromeBelgium, Netherlands, Germany, France, United States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedPancreatic CancerUnited States
-
Novartis PharmaceuticalsApproved for marketing
-
Novartis PharmaceuticalsCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis Pharmaceuticals; RECORDATI GROUPCompletedNeuroendocrine Tumors | Carcinoid TumorsUnited States
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
Montefiore Medical CenterNovartis PharmaceuticalsWithdrawnHyperinsulinism | Insulinoma | Congenital Hyperinsulinism
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Novartis PharmaceuticalsCompletedCushing's DiseaseItaly, Belgium, Japan, Germany, United Kingdom, Thailand, Spain, France, Netherlands, Turkey, Israel, China, United States, Canada, India, Argentina, Brazil, Peru, Poland, Russian Federation
-
Novartis PharmaceuticalsCompletedAcromegalyUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Helsinki University Central HospitalCompletedSurgical Complications
-
Radboud University Medical CenterCompletedSymptomatic Dominant Liver CystNetherlands
-
South Florida Veterans Affairs Foundation for Research...Novartis PharmaceuticalsUnknownSmall Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedAlcoholism | Hepatic CirrhosisGermany, Belgium, United States, South Africa